{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:02:57Z","timestamp":1769558577087,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1136\/ard.2006.057901","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T02:58:50Z","timestamp":1161140330000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial"],"prefix":"10.1016","volume":"66","author":[{"given":"D D","family":"Gladman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Mease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Cifaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Perdok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Medich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.057901_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/ard.61.4.298","article-title":"Tumor necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors","volume":"61","author":"Mease","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.057901_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/ard.2004.032276","article-title":"Psoriasis treatment: current and emerging directed therapies","volume":"64","author":"Winterfield","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.057901_bib3","series-title":"Psoriasis and psoriatic arthritis: an integrated approach","first-page":"118","article-title":"Quality of life: psoriatic arthritis","author":"Gladman","year":"2004"},{"key":"10.1136\/ard.2006.057901_bib4","first-page":"127","article-title":"Psoriatic arthritis (PsA) \u2015 an analysis of 220 patients","volume":"62","author":"Gladman","year":"1987","journal-title":"QJM"},{"key":"10.1136\/ard.2006.057901_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mjd.2001.110880","article-title":"Use of the Dermatology Life Quality Index (DLQI) in a Midwestern US urban clinic","volume":"45","author":"Hahn","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2006.057901_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/30.4.245","article-title":"Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients","volume":"30","author":"Torre Alonso","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib7","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.057901_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1067\/mjd.2002.119669","article-title":"The direct cost of care for psoriasis and psoriatic arthritis in the United States","volume":"46","author":"Javitz","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2006.057901_bib9","first-page":"721","article-title":"Employment across chronic inflammatory rheumatic diseases and comparison with the general population","volume":"32","author":"Mau","year":"2005","journal-title":"J Rheumatol"},{"issue":"Suppl II","key":"10.1136\/ard.2006.057901_bib10","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"Suppl II","key":"10.1136\/ard.2006.057901_bib11","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1136\/ard.2004.030767","article-title":"Discussion: clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.057901_bib12","first-page":"511","article-title":"Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis","volume":"24","author":"Husted","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00015550252948130","article-title":"Quality of life and prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study","volume":"82","author":"Zachariae","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1136\/ard.2006.057901_bib14","first-page":"809","article-title":"Longitudinal study of clinical and radiological progression in psoriatic arthritis","volume":"17","author":"Gladman","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.9.7.1511","article-title":"Psoriatic arthritis","volume":"9","author":"Gladman","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1136\/ard.2006.057901_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health-related quality of life in patients with psoriatic arthritis. A comparison with patients with rheumatoid arthritis","volume":"45","author":"Husted","year":"2001","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard.2006.057901_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/art.21177","article-title":"Description and prediction of physical functional disability in psoriatic arthritis: a longitudinal analysis using a Markov model approach","volume":"53","author":"Husted","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.057901_bib18","first-page":"1842","article-title":"Comparison of disability and quality of life in rheumatoid and psoriatic arthritis","volume":"28","author":"Sokoll","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib19","first-page":"1041","article-title":"Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis","volume":"28","author":"Rahman","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib20","first-page":"439","article-title":"A modified version of the health assessment questionnaire (HAQ)","volume":"13","author":"Husted","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the United States population","volume":"53","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2006.057901_bib22","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab in the treatment of patients with moderately to severely active psoriatic arthritis: results of ADEPT","volume":"52","author":"Mease","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.057901_bib23","first-page":"789","article-title":"The dimensions of health outcomes: the Health Assessment Questionnaire, Disability and Pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib24","first-page":"2146","article-title":"Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis","volume":"25","author":"Husted","year":"1998","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1136\/ard.2006.057901_bib25","first-page":"391","article-title":"How much improvement in functional status is considered important by patients with active psoriatic arthritis: applying the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) group guidelines [abstract]","volume":"63","author":"Mease","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"Suppl II","key":"10.1136\/ard.2006.057901_bib26","doi-asserted-by":"crossref","first-page":"ii49","DOI":"10.1136\/ard.2004.034165","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.057901_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). 1. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1136\/ard.2006.057901_bib28","series-title":"SF-36 Health Survey. Manual and interpretation guide","author":"Ware","year":"2002"},{"key":"10.1136\/ard.2006.057901_bib29","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M","article-title":"Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis","volume":"43","author":"Kosinski","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.057901_bib30","first-page":"811","article-title":"Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis","volume":"32","author":"Cella","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.057901_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cncr.10245","article-title":"Fatigue in cancer patients compared with fatigue in the general United States population","volume":"94","author":"Cella","year":"2002","journal-title":"Cancer"},{"key":"10.1136\/ard.2006.057901_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1136\/ard.2006.057901_bib33","article-title":"The FACIT-Fatigue scale is valid in patients with psoriatic arthritis (PsA)","volume":"52","author":"Chandran","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.057901_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2015a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1136\/ard.2006.057901_bib35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/000155500750012153","article-title":"Dermatology Life Quality Index: data from Danish inpatients and outpatients","volume":"80","author":"Zachariae","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1136\/ard.2006.057901_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/000155502320624078","article-title":"The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics","volume":"82","author":"Mork","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1136\/ard.2006.057901_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2133.1999.03112.x","article-title":"Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to the DLQI","volume":"141","author":"Badia","year":"1999","journal-title":"Br J Dermatol"},{"issue":"Suppl 62","key":"10.1136\/ard.2006.057901_bib38","first-page":"50","article-title":"Clinical meaning of change in Dermatology Life Quality Index scores","volume":"147","author":"Khilji","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.2006.057901_bib39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaad.2005.06.053","article-title":"Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial","volume":"53","author":"Feldman","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1136\/ard.2006.057901_bib40","article-title":"Minimum clinically important difference in Dermatology Life Quality Index in moderate to severe plaque psoriasis patients treated with adalimumab","volume":"54","author":"Melilli","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724300500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724300500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.057901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:21:16Z","timestamp":1737530476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724300500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0003496724300500"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.057901","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.057901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}